Literature DB >> 25971593

Prefrontal Cortical Kappa Opioid Receptors Attenuate Responses to Amygdala Inputs.

Hugo A Tejeda1, Ashley N Hanks2, Liam Scott2, Carlos Mejias-Aponte3, Zoë A Hughes2, Patricio O'Donnell1,2,4.   

Abstract

Kappa opioid receptors (KORs) have been implicated in anxiety and stress, conditions that involve activation of projections from the basolateral amygdala (BLA) to the medial prefrontal cortex (mPFC). Although KORs have been studied in several brain regions, their role on mPFC physiology and on BLA projections to the mPFC remains unclear. Here, we explored whether KORs modify synaptic inputs from the BLA to the mPFC using in vivo electrophysiological recordings with electrical and optogenetic stimulation. Systemic administration of the KOR agonist U69,593 inhibited BLA-evoked synaptic responses in the mPFC without altering hippocampus-evoked responses. Intra-mPFC U69,593 inhibited electrical and optogenetic BLA-evoked synaptic responses, an effect blocked by the KOR antagonist nor-BNI. Bilateral intra-mPFC injection of the KOR antagonist nor-BNI increased center time in the open field test, suggesting an anxiolytic effect. The data demonstrate that mPFC KORs negatively regulate glutamatergic synaptic transmission in the BLA-mPFC pathway and anxiety-like behavior. These findings provide a framework whereby KOR signaling during stress and anxiety can regulate the flow of emotional state information from the BLA to the mPFC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25971593      PMCID: PMC4864622          DOI: 10.1038/npp.2015.138

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  29 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  Amygdala input to medial prefrontal cortex (mPFC) in the rat: a light and electron microscope study.

Authors:  S J Bacon; A J Headlam; P L Gabbott; A D Smith
Journal:  Brain Res       Date:  1996-05-13       Impact factor: 3.252

3.  Amygdala inputs drive feedforward inhibition in the medial prefrontal cortex.

Authors:  Jonathan Dilgen; Hugo A Tejeda; Patricio O'Donnell
Journal:  J Neurophysiol       Date:  2013-05-08       Impact factor: 2.714

Review 4.  Role of kappa-opioid receptors in stress and anxiety-related behavior.

Authors:  Ashlee Van't Veer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

5.  Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion.

Authors:  Hugo A Tejeda; Danielle S Counotte; Eric Oh; Sammanda Ramamoorthy; Kristin N Schultz-Kuszak; Cristina M Bäckman; Vladmir Chefer; Patricio O'Donnell; Toni S Shippenberg
Journal:  Neuropsychopharmacology       Date:  2013-03-29       Impact factor: 7.853

Review 6.  Emotion processing and regulation in bipolar disorder: a review.

Authors:  Jennifer Townsend; Lori L Altshuler
Journal:  Bipolar Disord       Date:  2012-06       Impact factor: 6.744

7.  Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity.

Authors:  Ashlee Van't Veer; Anita J Bechtholt; Sara Onvani; David Potter; Yujun Wang; Lee-Yuan Liu-Chen; Günther Schütz; Elena H Chartoff; Uwe Rudolph; Bruce M Cohen; William A Carlezon
Journal:  Neuropsychopharmacology       Date:  2013-02-27       Impact factor: 7.853

8.  Glutamate and aspartate immunoreactive neurons of the rat basolateral amygdala: colocalization of excitatory amino acids and projections to the limbic circuit.

Authors:  A J Mcdonald
Journal:  J Comp Neurol       Date:  1996-02-12       Impact factor: 3.215

9.  Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats.

Authors:  Brendan M Walker; Jessica L Kissler
Journal:  Neuropsychopharmacology       Date:  2013-05-21       Impact factor: 7.853

Review 10.  Development of κ opioid receptor antagonists.

Authors:  F Ivy Carroll; William A Carlezon
Journal:  J Med Chem       Date:  2013-02-14       Impact factor: 7.446

View more
  21 in total

Review 1.  Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.

Authors:  Rachel I Anderson; Howard C Becker
Journal:  Alcohol Clin Exp Res       Date:  2017-06-05       Impact factor: 3.455

2.  Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.

Authors:  Rachel I Anderson; David E Moorman; Howard C Becker
Journal:  Handb Exp Pharmacol       Date:  2018

3.  Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders.

Authors:  E Domi; E Barbier; E Augier; G Augier; D Gehlert; R Barchiesi; A Thorsell; L Holm; M Heilig
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

4.  Predicting personality from network-based resting-state functional connectivity.

Authors:  Alessandra D Nostro; Veronika I Müller; Deepthi P Varikuti; Rachel N Pläschke; Felix Hoffstaedter; Robert Langner; Kaustubh R Patil; Simon B Eickhoff
Journal:  Brain Struct Funct       Date:  2018-03-23       Impact factor: 3.270

Review 5.  Opioid modulation of cognitive impairment in depression.

Authors:  Moriah L Jacobson; Hildegard A Wulf; Caroline A Browne; Irwin Lucki
Journal:  Prog Brain Res       Date:  2018-09-18       Impact factor: 2.453

Review 6.  Age as a factor in stress and alcohol interactions: A critical role for the kappa opioid system.

Authors:  Marvin Rafael Diaz; Kathryn Renee Przybysz; Siara K Rouzer
Journal:  Alcohol       Date:  2017-10-12       Impact factor: 2.405

Review 7.  Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.

Authors:  Elyssa B Margolis; Anushree N Karkhanis
Journal:  Neurochem Int       Date:  2019-07-10       Impact factor: 3.921

Review 8.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

9.  Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis.

Authors:  Chloe M Erikson; Gengze Wei; Brendan M Walker
Journal:  Neuropharmacology       Date:  2018-07-31       Impact factor: 5.250

10.  Maturational alterations in constitutive activity of medial prefrontal cortex kappa-opioid receptors in Wistar rats.

Authors:  Sunil Sirohi; Brendan M Walker
Journal:  J Neurochem       Date:  2015-09-11       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.